Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sean Salmon Insider Profile
4 Followers
Sean Salmon, EVP & President Cardiovascular at Medtronic, holds 48.29K shares in Medtronic (Ticker: MDT). Most recently, Sean Salmon Sold $30,695 shares of Medtronic on Feb 23, 2024 for an estimated value of 2.61M.
Sean Salmon Medtronic (MDT)EVP & President Cardiovascular
Medtronic (MDT)
EVP & President Cardiovascular
Ranked #35,878 out of 98,564 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+8.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP & President Cardiovascular
Roles that Sean Salmon holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sean Salmon
Sean Salmon's Trading History
List of latest transactions for each holding click on a transaction to see Sean Salmon's performance on stock
You May Also Like
Sean Salmon insider profile FAQ
What is the percentage of profitable transactions made by Sean Salmon?
The percentage of profitable transactions made by Sean Salmon is 67%.
What is the average return per transaction made by Sean Salmon?
The average return per transaction made by Sean Salmon is 8.70%.
What stocks does Sean Salmon hold?
Sean Salmon holds: MDT stocks.
What was Sean Salmon’s latest transaction?
Sean Salmon latest transaction was an Informative Sell of $2.61M.
What was Sean Salmon's most profitable transaction?
Sean Salmon’s most profitable transaction was an Informative Sell of MDT stock on August 26, 2021. The return on the trade was 31.20%.
What is Sean Salmon's role in Medtronic?
Sean Salmon's role in Medtronic is EVP & President Cardiovascular.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.